Epitol Dosage

A healthcare provider will consider several factors before prescribing Epitol. Some of these factors that may affect your Epitol dosage include your age and weight, the condition being treated, other medications you are taking, and other medical conditions you have. Typically, the starting Epitol dose for treating epilepsy in adults and children (over 12 years old) is 200 mg twice daily. For treating trigeminal neuralgia, the starting dose is 100 mg twice daily. Your healthcare provider may slowly increase the dosage to control your symptoms.

 

An Introduction to Epitol Dosage

The dose of Epitol® (carbamazepine) that your healthcare provider recommends will vary depending on a number of factors, including:
 
  • Your age and weight
  • The condition being treated
  • Other medications you may be taking
  • Other medical conditions you may have.
     
As always, do not adjust your Epitol dosage unless your healthcare provider specifically instructs you to do so.
 

Epitol Dosage for Epilepsy

The dose of Epitol for epilepsy treatment depends on your age and weight. For adults and children over 12 years old, the recommended starting dose is Epitol 200 mg twice daily. For children ages 6 to 12 years old, the recommended starting dose is Epitol 100 mg (half a tablet) twice daily. For children who are less than six years old, the starting dose is based on weight -- Epitol 10 mg to 20 mg per kg total per day (about 4.5 mg to 9 mg per pound per day), split up into two or three doses per day. Young children who have difficulty swallowing tablets may need to use a different form of carbamazepine (such as Tegretol® chewable tablets or suspension).
 
Your healthcare provider will increase your Epitol dose slowly as necessary to control your seizures. Increased dosages (beyond the starting dose) are usually taken three or four times a day.
 
(Epitol Dosage Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;